What It Is
Tirzepatide is a dual GIP/GLP-1 receptor agonist — the same class as Mounjaro® and Zepbound®. It targets two hormonal pathways instead of one, often producing stronger results.
How It Works
By activating both GIP and GLP-1 receptors, tirzepatide provides a dual-action approach to appetite control, blood sugar regulation, and metabolic enhancement.
Who It's For
Adults seeking maximum pharmaceutical weight management support, especially those who may have plateaued on single-pathway GLP-1 medications.
Who Should Avoid It
Same as semaglutide: avoid with thyroid cancer history, MEN2, pancreatitis, gastroparesis, or pregnancy.
Protocol & Pricing
OBP Pharmacy Price
From $100/vial
You pay pharmacy price. No markup.
Starting Dose
2.5mg/week
Form
Injectable vial
Dosing Protocol
Start at 2.5mg/week subcutaneous injection, titrate every 4 weeks. Provider-guided escalation.
Stacking Guide
Stacks Well With
Do Not Combine With
Related Peptides
GLP-1 medications are compounded semaglutide/tirzepatide. Compounded versions are not the same as branded Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Compounded medications are prepared by licensed pharmacies and are not FDA-approved drug products.